PLT and Steroid in Lateral Epicondylopathy and Supraspinatus Calcific Tendinopathy

National Taiwan University

Status and phase: Enrolling; Phase 3

Conditions: Rotator Cuff Syndrome; Lateral Epicondylitis

Treatments: Combination Product: lyophilized platelet (30ng) and triamcinolone acetonide 10mg; Other: lyophilized platelet (30ng); Drug: triamcinolone acetonide 10mg

Study type: Interventional

Funder types: Other

Identifiers

NCT05648032

201903076DIPC

Details and patient eligibility

About

PLT vs. steroid vs. PLT + steroid, which treatment is most effective in lateral epicondylitis (or tennis elbow) and supraspinatus calcific tendinitis.

Full description

Lateral epicondylitis (or tennis elbow) and supraspinatus calcific tendinitis are common tendinopathies of the upper limb and both have negative impacts on the patients' quality of life. The former affects function of wrist extension due to degeneration of common extensor tendons; the latter causes severe pain and limitation of shoulder range of motion due to calcific deposits within the supraspinatus tendon. Current common injection therapies are ultrasound-guided injection of steroid or platelet-rich plasma (PRP).

Previous studies have shown that steroid injection provides early but short-term pain reduction, while PRP injection causes post-injection pain by inducing inflammation but provides long-term pain relief and functional improvement. It may provide early pain reduction with long-term tissue regeneration if combining steroid and PRP. A recent study on tennis elbow showed that inclusion of steroid in the autologous whole blood and 20% dextrose injection can reduce pain during early treatment, without interfering with the therapeutic effects.

Furthermore, disadvantages of current PRP include difficulty in quantifying platelet numbers and growth factor activity, and in long-term preservation. In this study lyophilized platelet (PLT) can solve these problems, which can be dissolved in saline before injection.

This 3-arm randomized controlled trial will divide subjects into the PLT group (group A), steroid group (group B) or PLT+steroid group (group C). Therapeutic effects will be evaluated by pain visual analogue scale (VAS), grip dynamometer, and disabilities of the arm, shoulder, and hand (DASH) questionnaires during follow-ups at 2nd, 4th, 6th, 12th and 24th week after treatment, and ultrasound at 12th and 24th week . The hypothesis is that PLT+steroid injection will have earlier pain reduction than PLT injection and longer effects of pain reduction and functional improvement.

Enrollment: 180 estimated patients

Sex: All

Ages: 25 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Lateral epicondylitis

Inclusion Criteria:

• Tenderness at lateral epicondyle more than 3 months
• Ultrasound-confirmed lateral epicondylopathy
• Pain VAS ≥ 3/10 during wrist resistive extension
• No treatment response to NSAID and physiotherapy

Exclusion Criteria:

• Pregnancy or lactation
• Carpal tunnel syndrome (the same arm) in one year
• Cervical radiculopathy
• Taking NSAID in one week
• Receiving PRP or steroid injection in one month
• History of bacteremia, cellulitis or skin ulcer in three months
• Rheumatoid arthritis
• Malignancy
• Poorly controlled diabetets mellitus (DM), liver and kidner diseases
• Severe anemia (Hb<5)
• Thrombocytopenia
• History of tennis elbow surgery
• History of elbow trauma

Supraspinatus calcific tendinis

Inclusion Criteria:

• Hawkins-Kennedy test or empty can test, one of which is positive
• Ultrasound-confirmed (calcification > 2mm)
• Pain VAS ≥ 3/10 over right deltoid area more than 3 months
• No treatment response to NSAID and physiotherapy

Exclusion Criteria:

• Pregnancy or lactation
• Carpal tunnel syndrome (the same arm) in one year
• Cervical radiculopathy
• Taking NSAID in one week
• Receiving PRP or steroid injection in one month
• History of bacteremia, cellulitis or skin ulcer in three months
• Rheumatoid arthritis
• Malignancy
• Poorly controlled DM, liver and kidner diseases
• Severe anemia (Hb<5)
• Thrombocytopenia
• History of shoulder surgery
• History of shoulder trauma

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

180 participants in 3 patient groups

PLT (lyophilized platelet) with steroid

Experimental group

Description:

PLT (30ng)+1.0 mL 1.0% Lidocaine+1.0 mL (10.0 mg/mL) Triamcinolone acetonide, once

Treatment:

Combination Product: lyophilized platelet (30ng) and triamcinolone acetonide 10mg

PLT (lyophilized platelet)

Experimental group

Description:

PLT (30ng)+1.0 mL 1.0% Lidocaine+1.0 mL normal saline, once

Treatment:

Other: lyophilized platelet (30ng)

Steroid

Active Comparator group

Description:

1.0 mL 1.0% Lidocaine+1.0 mL (10.0 mg/mL) Triamcinolone acetonide, once

Treatment:

Drug: triamcinolone acetonide 10mg